Who
Alissa Neufeld
Chief Legal Officer & Corp Sec
Company insider
Files Form 4 as: Chief Legal Officer & Corp Sec, Security National Financial; General Counsel, Lifevantage.
In numbers
- Trades disclosed
- 60
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 12 Aug 2021
- Last trade
- 11 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 14 Sep 2026 | SNFCA Security National Financialoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | $879K100,000 at $8.79 | filing |
| 11 Sep 2026filed 14 Sep 2026 | SNFCA Security National Financialoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | $879K100,000 at $8.79 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $8,3881,342 at $6.25 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $8,3881,342 at $6.25 | filing |
| 1 Apr 2026filed 3 Apr 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $6,0731,446 at $4.20 | filing |
| 1 Apr 2026filed 3 Apr 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $6,0731,446 at $4.20 | filing |
| 1 Jan 2026filed 5 Jan 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $8,9011,445 at $6.16 | filing |
| 1 Jan 2026filed 5 Jan 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $8,9011,445 at $6.16 | filing |
| 1 Oct 2025filed 3 Oct 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $12K1,283 at $9.56 | filing |
| 31 Aug 2025filed 3 Sep 2025 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code M | —14,498 at $0.00 | filing |
| 31 Aug 2025filed 3 Sep 2025 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,886 at $0.00 | filing |
| 31 Aug 2025filed 3 Sep 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code M | —14,498 at $0.00 | filing |
| 31 Aug 2025filed 3 Sep 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code M | —18,886 at $0.00 | filing |
| 31 Aug 2025filed 3 Sep 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $206K15,729 at $13.10 | filing |
| 26 Aug 2025filed 28 Aug 2025 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,554 at $0.00 | filing |
| 26 Aug 2025filed 28 Aug 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | —9,036 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,667 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code M | —2,667 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $37K2,799 at $13.39 | filing |
| 1 Apr 2025filed 3 Apr 2025 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,667 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.